179 related articles for article (PubMed ID: 36417756)
1. Synthesis and Characterization of NUC-7738, an Aryloxy Phosphoramidate of 3'-Deoxyadenosine, as a Potential Anticancer Agent.
Serpi M; Ferrari V; McGuigan C; Ghazaly E; Pepper C
J Med Chem; 2022 Dec; 65(23):15789-15804. PubMed ID: 36417756
[TBL] [Abstract][Full Text] [Related]
2. The Novel Nucleoside Analogue ProTide NUC-7738 Overcomes Cancer Resistance Mechanisms
Schwenzer H; De Zan E; Elshani M; van Stiphout R; Kudsy M; Morris J; Ferrari V; Um IH; Chettle J; Kazmi F; Campo L; Easton A; Nijman S; Serpi M; Symeonides S; Plummer R; Harrison DJ; Bond G; Blagden SP
Clin Cancer Res; 2021 Dec; 27(23):6500-6513. PubMed ID: 34497073
[TBL] [Abstract][Full Text] [Related]
3. Antileukemic activity and mechanism of action of cordycepin against terminal deoxynucleotidyl transferase-positive (TdT+) leukemic cells.
Kodama EN; McCaffrey RP; Yusa K; Mitsuya H
Biochem Pharmacol; 2000 Feb; 59(3):273-81. PubMed ID: 10609556
[TBL] [Abstract][Full Text] [Related]
4. Transepithelial fluxes of adenosine and 2'-deoxyadenosine across human renal proximal tubule cells: roles of nucleoside transporters hENT1, hENT2, and hCNT3.
Elwi AN; Damaraju VL; Kuzma ML; Mowles DA; Baldwin SA; Young JD; Sawyer MB; Cass CE
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1439-51. PubMed ID: 19297449
[TBL] [Abstract][Full Text] [Related]
5. NUC-7738 regulates β-catenin signalling resulting in reduced proliferation and self-renewal of AML cells.
Shahid AM; Um IH; Elshani M; Zhang Y; Harrison DJ
PLoS One; 2022; 17(12):e0278209. PubMed ID: 36520954
[TBL] [Abstract][Full Text] [Related]
6. Formation and degradation of deoxyadenosine nucleotides in inherited adenosine deaminase deficiency.
Simmonds HA; Webster DR; Perrett D; Reiter S; Levinsky RJ
Biosci Rep; 1982 May; 2(5):303-14. PubMed ID: 6980023
[TBL] [Abstract][Full Text] [Related]
7. The cytostatic activity of NUC-3073, a phosphoramidate prodrug of 5-fluoro-2'-deoxyuridine, is independent of activation by thymidine kinase and insensitive to degradation by phosphorolytic enzymes.
Vande Voorde J; Liekens S; McGuigan C; Murziani PG; Slusarczyk M; Balzarini J
Biochem Pharmacol; 2011 Sep; 82(5):441-52. PubMed ID: 21658373
[TBL] [Abstract][Full Text] [Related]
8. Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Ho AD; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand AV; Hunstein W
Leuk Res; 1989; 13(4):269-78. PubMed ID: 2785618
[TBL] [Abstract][Full Text] [Related]
9. Single Diastereomers of the Clinical Anticancer ProTide Agents NUC-1031 and NUC-3373 Preferentially Target Cancer Stem Cells
Slusarczyk M; Serpi M; Ghazaly E; Kariuki BM; McGuigan C; Pepper C
J Med Chem; 2021 Jun; 64(12):8179-8193. PubMed ID: 34085825
[TBL] [Abstract][Full Text] [Related]
10. Activation of deoxycytidine kinase by deoxyadenosine: implications in deoxyadenosine-mediated cytotoxicity.
Keszler G; Virga S; Spasokoukotskaja T; Bauer PI; Sasvari-Szekely M; Staub M
Arch Biochem Biophys; 2005 Apr; 436(1):69-77. PubMed ID: 15752710
[TBL] [Abstract][Full Text] [Related]
11. Rejection of bone marrow transplant and resistance of alloantigen reactive cells to in vivo deoxyadenosine in adenosine deaminase deficiency.
Cowan MJ; Shannon KM; Wara DW; Ammann AJ
Clin Immunol Immunopathol; 1988 Nov; 49(2):242-50. PubMed ID: 2971490
[TBL] [Abstract][Full Text] [Related]
12. Morphological changes in leukemic lymphoblasts and normal lymphocytes treated with deoxyadenosine plus deoxycoformycin.
Matsumoto SS; Yu AL; Yu J
Cancer Invest; 1985; 3(3):225-33. PubMed ID: 3873981
[TBL] [Abstract][Full Text] [Related]
13. The role of human equilibrative nucleoside transporter 1 on the cellular transport of the DNA methyltransferase inhibitors 5-azacytidine and CP-4200 in human leukemia cells.
Hummel-Eisenbeiss J; Hascher A; Hals PA; Sandvold ML; Müller-Tidow C; Lyko F; Rius M
Mol Pharmacol; 2013 Sep; 84(3):438-50. PubMed ID: 23814180
[TBL] [Abstract][Full Text] [Related]
14. Purine deoxynucleoside toxicity in nondividing human lymphoid cells.
Kefford RF; Fox RM
Cancer Res; 1982 Jan; 42(1):324-30. PubMed ID: 6976204
[TBL] [Abstract][Full Text] [Related]
15. The combination of adenosine deaminase inhibition and deoxyadenosine induces apoptosis in a human astrocytoma cell line.
Garcia-Gil M; Tozzi MG; Varani S; Della Verde L; Petrotto E; Balestri F; Colombaioni L; Camici M
Neurochem Int; 2015 Jan; 80():14-22. PubMed ID: 25447764
[TBL] [Abstract][Full Text] [Related]
16. Application of ProTide technology to gemcitabine: a successful approach to overcome the key cancer resistance mechanisms leads to a new agent (NUC-1031) in clinical development.
Slusarczyk M; Lopez MH; Balzarini J; Mason M; Jiang WG; Blagden S; Thompson E; Ghazaly E; McGuigan C
J Med Chem; 2014 Feb; 57(4):1531-42. PubMed ID: 24471998
[TBL] [Abstract][Full Text] [Related]
17. Induction of apoptosis by cordycepin in ADA-inhibited TdT-positive leukemia cells.
Koç Y; Urbano AG; Sweeney EB; McCaffrey R
Leukemia; 1996 Jun; 10(6):1019-24. PubMed ID: 8667637
[TBL] [Abstract][Full Text] [Related]
18. Human B lymphocytes and thymocytes but not peripheral blood mononuclear cells accumulate high dATP levels in conditions simulating ADA deficiency.
Goday A; Simmonds HA; Morris GS; Fairbanks LD
Biochem Pharmacol; 1985 Oct; 34(19):3561-9. PubMed ID: 3876835
[TBL] [Abstract][Full Text] [Related]
19. Aryloxy phosphoramidate triesters: a technology for delivering monophosphorylated nucleosides and sugars into cells.
Mehellou Y; Balzarini J; McGuigan C
ChemMedChem; 2009 Nov; 4(11):1779-91. PubMed ID: 19760699
[TBL] [Abstract][Full Text] [Related]
20. Cordycepin (3'-Deoxyadenosine) Suppresses Heat Shock Protein 90 Function and Targets Tumor Growth in an Adenosine Deaminase-Dependent Manner.
Lee SC; Alaali L; Kwon H; Rigi M; Eberhart CG
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]